retatrutide safety trial results The Effect of on Kidney Parameters in Participants With Type 2 Diabetes Mellitus and/or Obesity Retatrutide yields results similar to

These findings highlight the importance of targeted therapeutic strategies based on HF phenotypes

The novel synergistically acting glucagon-like peptide-1 (GLP-1) receptor agonist combined with the amylin agonist, CagriSema, shows promising results in both glucose regulation and weight management

Live Akkermansia A next-generation beneficial strain essential for gut health, supporting microbiome balance and gut lining integrity

Tirzepatide 15 mg led to higher discontinuation rate of study medication due to adverse events regardless of comparator, while all tirzepatide doses were safe in terms of serious adverse events and mortality

Obesity is a chronic, complex medical condition